Avacopan (CCX168)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Avacopan (CCX168), covering 2020-07-27 to 2020-07-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis [Phase 2]